Perspectives and opportunities for novel antiviral treatments targeting virus fitness
Open Access
- 1 July 2008
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 14 (7) , 629-631
- https://doi.org/10.1111/j.1469-0691.2007.01937.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study)AIDS, 2006
- KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesisAntiviral Research, 2005
- Mechanistic Basis for Reduced Viral and Enzymatic Fitness of HIV-1 Reverse Transcriptase Containing Both K65R and M184V MutationsJournal of Biological Chemistry, 2004
- Processivity and drug-dependence of HIV-1 proteaseAIDS, 2003
- Error catastrophe and antiviral strategyProceedings of the National Academy of Sciences, 2002
- Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotypeAIDS, 1999
- Proposed alternatives for the use of anti-HIV drugsDrug Resistance Updates, 1999
- RNA VIRUS MUTATIONS AND FITNESS FOR SURVIVALAnnual Review of Microbiology, 1997
- On the nature of virus quasispeciesTrends in Microbiology, 1996
- Quasi-species: the concept and the wordPublished by Cambridge University Press (CUP) ,1995